Effects of Ezetimibe on the Absorption of Oxidized Cholesterol
Public ClinicalTrials.gov record NCT00794677. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, 2-Period, Crossover Study to Evaluate the Effects of Ezetimibe on the Plasma Appearance of 7-Ketocholesterol After an Oral Bolus in Patients With Primary Hypercholesterolemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to test the effects of Zetia™ (ezetimibe) 10 milligrams (mg) on the absorption of oxysterol into the blood following a meal containing oxysterol.
Study identification
- NCT ID
- NCT00794677
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2006
- Primary completion
- Jan 31, 2008
- Completion
- Aug 31, 2008
- Last update posted
- Mar 8, 2021
2006 – 2008
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cholesterol Research Center | Berkeley | California | 94705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Hypercholesterolemia trials
Other public records listing Hypercholesterolemia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07477704: A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia Recruiting
- NCT06451770: Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia Recruiting
- NCT06065098: Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health Active, not recruiting
- NCT00353782: Causes and Natural History of Dyslipidemias Recruiting
- NCT07447206: Vascular Intervention Strategies Trial for Alzheimer's Not yet recruiting
- NCT07514663: Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00794677, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 8, 2021 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00794677 live on ClinicalTrials.gov.